| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Isoflurane | 20 | 2018 | 380 | 2.560 |
Why?
|
| Anesthesia, General | 13 | 2021 | 1171 | 2.220 |
Why?
|
| Anesthetics, Inhalation | 20 | 2018 | 570 | 2.020 |
Why?
|
| Nitrous Oxide | 7 | 2008 | 177 | 1.430 |
Why?
|
| Preoperative Care | 5 | 2020 | 2250 | 1.200 |
Why?
|
| Delirium | 12 | 2023 | 1609 | 1.180 |
Why?
|
| Cognition Disorders | 11 | 2017 | 4043 | 1.020 |
Why?
|
| Anesthesia | 9 | 2023 | 1561 | 0.930 |
Why?
|
| Maze Learning | 9 | 2020 | 478 | 0.770 |
Why?
|
| Postoperative Complications | 13 | 2023 | 15295 | 0.690 |
Why?
|
| Propofol | 4 | 2016 | 629 | 0.610 |
Why?
|
| Aging | 10 | 2018 | 8664 | 0.590 |
Why?
|
| Anesthetics | 3 | 2010 | 539 | 0.590 |
Why?
|
| Cognition | 9 | 2021 | 6770 | 0.580 |
Why?
|
| Anesthesiology | 4 | 2014 | 1060 | 0.530 |
Why?
|
| Hippocampus | 7 | 2018 | 3675 | 0.530 |
Why?
|
| Rats, Inbred F344 | 9 | 2008 | 862 | 0.510 |
Why?
|
| Neurosciences | 2 | 2019 | 348 | 0.500 |
Why?
|
| Neurotransmitter Agents | 1 | 2018 | 647 | 0.500 |
Why?
|
| Memory | 5 | 2012 | 2174 | 0.480 |
Why?
|
| Memory Disorders | 4 | 2008 | 1184 | 0.470 |
Why?
|
| Physician Executives | 1 | 2014 | 128 | 0.440 |
Why?
|
| Laparotomy | 1 | 2015 | 473 | 0.440 |
Why?
|
| Geriatric Assessment | 2 | 2020 | 1372 | 0.440 |
Why?
|
| Anesthesia, Closed-Circuit | 1 | 2012 | 14 | 0.420 |
Why?
|
| Neural Stem Cells | 3 | 2018 | 851 | 0.420 |
Why?
|
| Central Nervous System | 1 | 2019 | 1357 | 0.400 |
Why?
|
| Entropy | 1 | 2012 | 209 | 0.390 |
Why?
|
| Nervous System | 2 | 2013 | 554 | 0.390 |
Why?
|
| Accreditation | 1 | 2014 | 450 | 0.380 |
Why?
|
| Publishing | 1 | 2018 | 833 | 0.380 |
Why?
|
| Social Environment | 1 | 2015 | 1023 | 0.360 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2005 | 895 | 0.350 |
Why?
|
| Specialties, Surgical | 1 | 2014 | 391 | 0.330 |
Why?
|
| Deep Sedation | 1 | 2010 | 121 | 0.320 |
Why?
|
| Dendritic Spines | 1 | 2010 | 233 | 0.320 |
Why?
|
| Rats | 17 | 2018 | 24260 | 0.320 |
Why?
|
| Neuropsychological Tests | 4 | 2021 | 6993 | 0.310 |
Why?
|
| Child Behavior | 1 | 2013 | 839 | 0.310 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2007 | 30 | 0.310 |
Why?
|
| Child Welfare | 1 | 2012 | 523 | 0.300 |
Why?
|
| Parkinson Disease | 1 | 2021 | 2775 | 0.300 |
Why?
|
| Orthopedic Procedures | 1 | 2017 | 1288 | 0.300 |
Why?
|
| Anesthesia, Inhalation | 1 | 2008 | 223 | 0.300 |
Why?
|
| Methyl Ethers | 3 | 2014 | 205 | 0.280 |
Why?
|
| Monitoring, Intraoperative | 2 | 2013 | 957 | 0.270 |
Why?
|
| Anesthetics, Intravenous | 2 | 2008 | 417 | 0.270 |
Why?
|
| Formaldehyde | 2 | 2004 | 353 | 0.260 |
Why?
|
| Conscious Sedation | 1 | 2010 | 528 | 0.260 |
Why?
|
| Age Factors | 9 | 2021 | 18370 | 0.250 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2004 | 57 | 0.250 |
Why?
|
| Genes, fos | 1 | 2004 | 183 | 0.240 |
Why?
|
| Dementia | 2 | 2016 | 2518 | 0.230 |
Why?
|
| Piperidines | 1 | 2012 | 1602 | 0.230 |
Why?
|
| Nicotinic Antagonists | 1 | 2003 | 96 | 0.230 |
Why?
|
| Pain Measurement | 2 | 2004 | 3420 | 0.230 |
Why?
|
| Spine | 2 | 2020 | 1144 | 0.220 |
Why?
|
| Amyloid beta-Peptides | 7 | 2014 | 3587 | 0.220 |
Why?
|
| Endovascular Procedures | 1 | 2016 | 1979 | 0.220 |
Why?
|
| Neurosurgery | 2 | 2013 | 643 | 0.210 |
Why?
|
| Animals | 36 | 2023 | 168757 | 0.210 |
Why?
|
| Psychomotor Performance | 4 | 2011 | 1901 | 0.210 |
Why?
|
| Brain Ischemia | 1 | 2016 | 3265 | 0.210 |
Why?
|
| Nervous System Diseases | 2 | 2014 | 1622 | 0.210 |
Why?
|
| Child Development | 1 | 2013 | 2223 | 0.210 |
Why?
|
| Synapses | 2 | 2017 | 1728 | 0.200 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 1432 | 0.200 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2291 | 0.200 |
Why?
|
| Space Perception | 1 | 2004 | 475 | 0.200 |
Why?
|
| Caspase 3 | 5 | 2016 | 758 | 0.200 |
Why?
|
| Anesthesia, Spinal | 1 | 2004 | 269 | 0.190 |
Why?
|
| Brain | 8 | 2020 | 26385 | 0.190 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 3537 | 0.190 |
Why?
|
| Alzheimer Disease | 6 | 2023 | 8037 | 0.190 |
Why?
|
| Stroke | 3 | 2016 | 9981 | 0.190 |
Why?
|
| Receptors, Nicotinic | 1 | 2003 | 497 | 0.180 |
Why?
|
| Olfaction Disorders | 1 | 2022 | 222 | 0.180 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 433 | 0.180 |
Why?
|
| Interleukin-1beta | 2 | 2018 | 972 | 0.170 |
Why?
|
| Behavior, Animal | 3 | 2020 | 1881 | 0.170 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2002 | 365 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2018 | 8301 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2015 | 18029 | 0.160 |
Why?
|
| Longevity | 1 | 2006 | 1070 | 0.160 |
Why?
|
| Humans | 47 | 2023 | 744343 | 0.150 |
Why?
|
| Environmental Exposure | 1 | 2012 | 4234 | 0.150 |
Why?
|
| Neurons | 5 | 2018 | 9338 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2012 | 3658 | 0.140 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 617 | 0.140 |
Why?
|
| Spinal Cord | 1 | 2004 | 1809 | 0.140 |
Why?
|
| Male | 27 | 2021 | 350118 | 0.130 |
Why?
|
| Surgical Procedures, Operative | 2 | 2020 | 1876 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2018 | 4420 | 0.130 |
Why?
|
| Staurosporine | 2 | 2016 | 251 | 0.130 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 15076 | 0.130 |
Why?
|
| Research | 1 | 2003 | 1999 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2018 | 2408 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 10 | 2018 | 21827 | 0.120 |
Why?
|
| Oxytocin | 1 | 2018 | 394 | 0.120 |
Why?
|
| Aged | 13 | 2023 | 163280 | 0.110 |
Why?
|
| Prenatal Injuries | 1 | 2013 | 13 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2014 | 5788 | 0.110 |
Why?
|
| Neurogenesis | 2 | 2018 | 838 | 0.110 |
Why?
|
| Interleukin-10 | 1 | 2018 | 1200 | 0.110 |
Why?
|
| Tight Junctions | 1 | 2015 | 311 | 0.110 |
Why?
|
| Apoptosis | 5 | 2016 | 9727 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 430 | 0.110 |
Why?
|
| Interleukin-6 | 4 | 2022 | 3200 | 0.100 |
Why?
|
| Deoxyuridine | 1 | 2011 | 33 | 0.100 |
Why?
|
| Models, Animal | 1 | 2018 | 2171 | 0.100 |
Why?
|
| Propidium | 1 | 2011 | 41 | 0.100 |
Why?
|
| Fellowships and Scholarships | 2 | 2013 | 1076 | 0.100 |
Why?
|
| Acute Lung Injury | 1 | 2015 | 380 | 0.100 |
Why?
|
| Enzyme Activation | 7 | 2014 | 3701 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 1677 | 0.100 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2216 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 5708 | 0.100 |
Why?
|
| Neurology | 1 | 2019 | 763 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 2731 | 0.090 |
Why?
|
| Microglia | 1 | 2019 | 1266 | 0.090 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 269 | 0.090 |
Why?
|
| Efficiency | 1 | 2014 | 462 | 0.090 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2011 | 424 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10481 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 9438 | 0.090 |
Why?
|
| Random Allocation | 3 | 2013 | 2429 | 0.090 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2011 | 284 | 0.090 |
Why?
|
| Mice | 14 | 2023 | 81183 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3508 | 0.090 |
Why?
|
| Female | 21 | 2021 | 380194 | 0.090 |
Why?
|
| Neuroglia | 3 | 2018 | 927 | 0.090 |
Why?
|
| Culture Media | 1 | 2011 | 908 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1580 | 0.090 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 11366 | 0.090 |
Why?
|
| Carcinogens | 1 | 2011 | 466 | 0.080 |
Why?
|
| Oxygen | 1 | 2021 | 4189 | 0.080 |
Why?
|
| Pain | 1 | 2004 | 4986 | 0.080 |
Why?
|
| Coloring Agents | 1 | 2011 | 566 | 0.080 |
Why?
|
| Prospective Studies | 6 | 2022 | 53288 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 2002 | 0.080 |
Why?
|
| Caspases | 2 | 2008 | 928 | 0.080 |
Why?
|
| Length of Stay | 2 | 2020 | 6309 | 0.080 |
Why?
|
| Memantine | 1 | 2008 | 100 | 0.080 |
Why?
|
| Risk Factors | 6 | 2023 | 72290 | 0.070 |
Why?
|
| Inflammation | 2 | 2019 | 10638 | 0.070 |
Why?
|
| Nerve Net | 1 | 2019 | 2174 | 0.070 |
Why?
|
| Neurotoxins | 1 | 2008 | 237 | 0.070 |
Why?
|
| Haplorhini | 1 | 2007 | 552 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 9959 | 0.070 |
Why?
|
| Child Behavior Disorders | 1 | 2011 | 807 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5078 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 7279 | 0.070 |
Why?
|
| Cell Death | 1 | 2011 | 1706 | 0.070 |
Why?
|
| Amyloid Precursor Protein Secretases | 4 | 2014 | 584 | 0.070 |
Why?
|
| Gene Expression | 1 | 2018 | 7799 | 0.070 |
Why?
|
| Patient Care | 1 | 2011 | 640 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2019 | 8554 | 0.060 |
Why?
|
| Cells, Cultured | 4 | 2018 | 19229 | 0.060 |
Why?
|
| Anesthetics, Combined | 1 | 2004 | 40 | 0.060 |
Why?
|
| Cytosol | 1 | 2008 | 901 | 0.060 |
Why?
|
| Learning | 2 | 2012 | 1713 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2012 | 2740 | 0.060 |
Why?
|
| Ephedrine | 1 | 2004 | 54 | 0.060 |
Why?
|
| Respiratory Protective Devices | 1 | 2004 | 45 | 0.060 |
Why?
|
| Mitochondria | 2 | 2020 | 3520 | 0.060 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 2023 | 36 | 0.060 |
Why?
|
| Laryngeal Masks | 1 | 2004 | 99 | 0.060 |
Why?
|
| Boston | 1 | 2016 | 9313 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 748 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2759 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2011 | 1456 | 0.060 |
Why?
|
| Nasal Septum | 1 | 2004 | 127 | 0.050 |
Why?
|
| Nuclease Protection Assays | 1 | 2002 | 16 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2007 | 705 | 0.050 |
Why?
|
| Hypoxia, Brain | 1 | 2003 | 133 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1889 | 0.050 |
Why?
|
| Pregnancy | 5 | 2018 | 29144 | 0.050 |
Why?
|
| Hypercapnia | 1 | 2003 | 260 | 0.050 |
Why?
|
| Paranasal Sinuses | 1 | 2004 | 250 | 0.050 |
Why?
|
| Hip Fractures | 1 | 2010 | 955 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 1422 | 0.050 |
Why?
|
| Portugal | 1 | 2021 | 87 | 0.050 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2021 | 34 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2014 | 3313 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2011 | 4462 | 0.050 |
Why?
|
| Vasoconstrictor Agents | 1 | 2004 | 642 | 0.050 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2004 | 312 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 57776 | 0.050 |
Why?
|
| Hospitals | 1 | 2014 | 3952 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 1581 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2023 | 690 | 0.050 |
Why?
|
| tau Proteins | 2 | 2023 | 1868 | 0.040 |
Why?
|
| Curriculum | 1 | 2013 | 3605 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2021 | 23338 | 0.040 |
Why?
|
| Prevalence | 1 | 2016 | 15226 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2006 | 1184 | 0.040 |
Why?
|
| Time | 1 | 2020 | 542 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4751 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2019 | 520 | 0.040 |
Why?
|
| Motivation | 1 | 2008 | 1971 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2023 | 8436 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2019 | 256 | 0.040 |
Why?
|
| Clioquinol | 2 | 2008 | 23 | 0.040 |
Why?
|
| Vitamin K 2 | 1 | 2017 | 47 | 0.040 |
Why?
|
| Receptors, Oxytocin | 1 | 2018 | 66 | 0.040 |
Why?
|
| Synaptophysin | 1 | 2017 | 141 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3920 | 0.040 |
Why?
|
| Leadership | 1 | 2007 | 1357 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 9734 | 0.040 |
Why?
|
| Time Factors | 3 | 2016 | 40075 | 0.040 |
Why?
|
| Hypotension | 1 | 2003 | 884 | 0.040 |
Why?
|
| Dentate Gyrus | 1 | 2017 | 160 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2004 | 1002 | 0.040 |
Why?
|
| Cell Survival | 3 | 2016 | 5882 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2012 | 5179 | 0.040 |
Why?
|
| Catheterization | 1 | 2002 | 1470 | 0.040 |
Why?
|
| Probiotics | 1 | 2020 | 351 | 0.030 |
Why?
|
| Patient Selection | 1 | 2008 | 4215 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2020 | 693 | 0.030 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2008 | 311 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2021 | 721 | 0.030 |
Why?
|
| General Surgery | 1 | 2007 | 1636 | 0.030 |
Why?
|
| Pyramidal Cells | 1 | 2017 | 363 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 25043 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2004 | 2564 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6365 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2017 | 732 | 0.030 |
Why?
|
| Calcium | 1 | 2008 | 5756 | 0.030 |
Why?
|
| Escape Reaction | 1 | 2014 | 54 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 8949 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2019 | 1842 | 0.030 |
Why?
|
| Cell Line, Tumor | 5 | 2009 | 16689 | 0.030 |
Why?
|
| Oligodendroglia | 1 | 2018 | 517 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 898 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 3870 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2011 | 1121 | 0.030 |
Why?
|
| Ibuprofen | 1 | 2014 | 236 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2021 | 63114 | 0.030 |
Why?
|
| Respiratory Mucosa | 1 | 2015 | 427 | 0.030 |
Why?
|
| Oligopeptides | 2 | 2008 | 1189 | 0.030 |
Why?
|
| RNA | 1 | 2002 | 2749 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1738 | 0.030 |
Why?
|
| United States | 3 | 2011 | 69872 | 0.020 |
Why?
|
| Lithium | 1 | 2014 | 601 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 2025 | 0.020 |
Why?
|
| Reaction Time | 1 | 2017 | 2097 | 0.020 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2012 | 154 | 0.020 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2006 | 1121 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2010 | 4217 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2018 | 3002 | 0.020 |
Why?
|
| Astrocytes | 1 | 2018 | 1270 | 0.020 |
Why?
|
| Proteomics | 1 | 2023 | 3638 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2010 | 25625 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 1643 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2018 | 2504 | 0.020 |
Why?
|
| Placenta | 1 | 2018 | 1698 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 1162 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 12072 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 1105 | 0.020 |
Why?
|
| Abdomen | 1 | 2014 | 1118 | 0.020 |
Why?
|
| Phlebotomy | 1 | 2008 | 141 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 2726 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2008 | 231 | 0.020 |
Why?
|
| Ganglioglioma | 1 | 2007 | 42 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 436 | 0.020 |
Why?
|
| Denervation | 1 | 2008 | 278 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2007 | 190 | 0.020 |
Why?
|
| Carbamates | 1 | 2008 | 196 | 0.020 |
Why?
|
| Spinal Puncture | 1 | 2008 | 281 | 0.020 |
Why?
|
| Health Status | 1 | 2019 | 4034 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 1970 | 0.020 |
Why?
|
| Cholinergic Antagonists | 1 | 2006 | 165 | 0.020 |
Why?
|
| Dipeptides | 1 | 2008 | 409 | 0.020 |
Why?
|
| Fear | 1 | 2014 | 1440 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2007 | 380 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 675 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2008 | 812 | 0.020 |
Why?
|
| Plaque, Amyloid | 1 | 2009 | 729 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 7322 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2006 | 621 | 0.020 |
Why?
|
| Incidence | 1 | 2023 | 20947 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1790 | 0.020 |
Why?
|
| Copper | 1 | 2007 | 366 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2019 | 6150 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 2077 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2007 | 780 | 0.010 |
Why?
|
| Wound Healing | 1 | 2014 | 2785 | 0.010 |
Why?
|
| Zinc | 1 | 2007 | 684 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 2004 | 290 | 0.010 |
Why?
|
| Serotonin | 1 | 2006 | 1017 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2006 | 1792 | 0.010 |
Why?
|
| Radiography | 1 | 2013 | 7023 | 0.010 |
Why?
|
| Middle Aged | 3 | 2023 | 213383 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5974 | 0.010 |
Why?
|
| Melatonin | 1 | 2006 | 721 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 77449 | 0.010 |
Why?
|
| Motor Activity | 1 | 2011 | 2714 | 0.010 |
Why?
|
| Amino Acids | 1 | 2006 | 1736 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11483 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2006 | 2634 | 0.010 |
Why?
|
| Body Weight | 1 | 2011 | 4669 | 0.010 |
Why?
|
| Critical Care | 1 | 2013 | 2647 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 1990 | 0.010 |
Why?
|
| Triglycerides | 1 | 2006 | 2454 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3798 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 3772 | 0.010 |
Why?
|
| Health Surveys | 1 | 2008 | 4037 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 40561 | 0.010 |
Why?
|
| Pediatrics | 1 | 2013 | 3475 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 15997 | 0.010 |
Why?
|
| Anxiety | 1 | 2011 | 4297 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2004 | 1364 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 3022 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5097 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2008 | 3309 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9583 | 0.010 |
Why?
|
| Glioma | 1 | 2006 | 3401 | 0.010 |
Why?
|
| Adult | 2 | 2013 | 214055 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 8863 | 0.000 |
Why?
|
| Child | 1 | 2013 | 77709 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 35421 | 0.000 |
Why?
|